
Patricia L Morris
Examiner (ID: 11378, Phone: (571)272-0688 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1203, 1201, 1209, 1625 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5410912
[patent_doc_number] => 20090124811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Method for resolving omeprazole salts'
[patent_app_type] => utility
[patent_app_number] => 12/201144
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9433
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201144 | Method for resolving omeprazole salts | Aug 28, 2008 | Issued |
Array
(
[id] => 5324357
[patent_doc_number] => 20090062347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED AXITINIB'
[patent_app_type] => utility
[patent_app_number] => 12/198034
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198034 | DEUTERIUM-ENRICHED AXITINIB | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5324356
[patent_doc_number] => 20090062346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'DEUTERIUM-ENRICHED TIPRANAVIR'
[patent_app_type] => utility
[patent_app_number] => 12/198050
[patent_app_country] => US
[patent_app_date] => 2008-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4437
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062346.pdf
[firstpage_image] =>[orig_patent_app_number] => 12198050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/198050 | DEUTERIUM-ENRICHED TIPRANAVIR | Aug 24, 2008 | Abandoned |
Array
(
[id] => 5453332
[patent_doc_number] => 20090069369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'DEUTERIUM-ENRICHED PRASUGREL'
[patent_app_type] => utility
[patent_app_number] => 12/196989
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3376
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196989
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196989 | Deuterium-enriched prasugrel | Aug 21, 2008 | Issued |
Array
(
[id] => 5272313
[patent_doc_number] => 20090076089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'DEUTERIUM-ENRICHED PANTOPRAZOLE'
[patent_app_type] => utility
[patent_app_number] => 12/196191
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5449
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196191 | DEUTERIUM-ENRICHED PANTOPRAZOLE | Aug 20, 2008 | Abandoned |
Array
(
[id] => 9232904
[patent_doc_number] => 08598208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Pyridine derivatives as S1P1/EDG1 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 12/673918
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41782
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673918
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673918 | Pyridine derivatives as S1P1/EDG1 receptor modulators | Aug 13, 2008 | Issued |
Array
(
[id] => 9469099
[patent_doc_number] => 08722730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => '5-membered heterocyclic compound'
[patent_app_type] => utility
[patent_app_number] => 12/673177
[patent_app_country] => US
[patent_app_date] => 2008-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17467
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673177 | 5-membered heterocyclic compound | Aug 13, 2008 | Issued |
Array
(
[id] => 8386379
[patent_doc_number] => 08263778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Process for producing pyripyropene derivatives and intermediates for the production thereof'
[patent_app_type] => utility
[patent_app_number] => 12/733113
[patent_app_country] => US
[patent_app_date] => 2008-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14588
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733113 | Process for producing pyripyropene derivatives and intermediates for the production thereof | Aug 12, 2008 | Issued |
Array
(
[id] => 5480954
[patent_doc_number] => 20090203911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'BENZIMIDAZOLE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/189590
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77556
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203911.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189590
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189590 | Benzimidazole compound | Aug 10, 2008 | Issued |
Array
(
[id] => 6249896
[patent_doc_number] => 20100137594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/733023
[patent_app_country] => US
[patent_app_date] => 2008-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40874
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137594.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733023
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733023 | TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT | Aug 6, 2008 | Abandoned |
Array
(
[id] => 5409471
[patent_doc_number] => 20090123369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques'
[patent_app_type] => utility
[patent_app_number] => 12/186072
[patent_app_country] => US
[patent_app_date] => 2008-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21143
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12186072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/186072 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques | Aug 4, 2008 | Issued |
Array
(
[id] => 5564954
[patent_doc_number] => 20090137807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Electrochromic material with improved lifetime'
[patent_app_type] => utility
[patent_app_number] => 12/222180
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5934
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12222180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/222180 | Electrochromic material with improved lifetime | Aug 3, 2008 | Abandoned |
Array
(
[id] => 4634546
[patent_doc_number] => 08012998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => 'Pyrrolidine aryl-ether as NK-3 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/185157
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29852
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/012/08012998.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185157
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185157 | Pyrrolidine aryl-ether as NK-3 receptor antagonists | Aug 3, 2008 | Issued |
Array
(
[id] => 4950142
[patent_doc_number] => 20080306268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Crystalline clopidogrel hydrobromide and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/221350
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8603
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221350 | Crystalline clopidogrel hydrobromide and processes for preparation thereof | Jul 30, 2008 | Abandoned |
Array
(
[id] => 4711883
[patent_doc_number] => 20080300409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Crystalline clopidogrel hydrobromide and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/221349
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8604
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221349
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221349 | Crystalline clopidogrel hydrobromide and processes for preparation thereof | Jul 30, 2008 | Abandoned |
Array
(
[id] => 5355678
[patent_doc_number] => 20090187022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Crystalline clopidogrel hydrobromide and processes for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/221257
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8602
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20090187022.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221257
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221257 | Crystalline clopidogrel hydrobromide and processes for preparation thereof | Jul 30, 2008 | Abandoned |
Array
(
[id] => 6592333
[patent_doc_number] => 20100130560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'FUNGICIDE 2-PYRIDYL-METHYLENE-THIO CARBOXAMIDE OR 2-PYRIDYL-METHYLENE-N-SUBSTITUTED CARBOXIMIDAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/452893
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9655
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452893 | FUNGICIDE 2-PYRIDYL-METHYLENE-THIO CARBOXAMIDE OR 2-PYRIDYL-METHYLENE-N-SUBSTITUTED CARBOXIMIDAMIDE DERIVATIVES | Jul 30, 2008 | Abandoned |
Array
(
[id] => 5509152
[patent_doc_number] => 20090082359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => '5-PYRIDINONE SUBSTITUTED INDAZOLES'
[patent_app_type] => utility
[patent_app_number] => 12/176144
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39082
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12176144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/176144 | 5-pyridinone substituted indazoles | Jul 17, 2008 | Issued |
Array
(
[id] => 6144610
[patent_doc_number] => 20110130377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'SUBSTITUTED ARYLOXAZOLES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 12/671019
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39250
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671019 | Substituted aryloxazoles and their use | Jul 16, 2008 | Issued |
Array
(
[id] => 6511899
[patent_doc_number] => 20100210847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'PROCESS FOR THE PREPARATION OF PANTOPRAZOLE SODIUM AND PANTOPRAZOLE SODIUM SESQUIHYDRATE'
[patent_app_type] => utility
[patent_app_number] => 12/669553
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3112
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669553 | PROCESS FOR THE PREPARATION OF PANTOPRAZOLE SODIUM AND PANTOPRAZOLE SODIUM SESQUIHYDRATE | Jul 16, 2008 | Abandoned |